Cat.#: ACPP-1341
| Despition | Pax2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1563 | Human STX4 Protein (AC1563) | 5 µg | inquiry |
| ACPP-1010 | Synthetic Nanodisc Human GPR56 Protein (AC1010) | 10 µg | inquiry |
| ACPP-1308 | TrkA Blocking Peptide (AC1308) | 250 µg | inquiry |
| ACPP-1821 | Human NT 4 Protein (AC1821) | 2 µg | inquiry |
| ACPP-1622 | Human DLK1 Protein (AC1622) | 2 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1390 | Human GDF11 Protein, His (AC1390) | 5 µg | inquiry |
| ACPP-1493 | Human Thyroid Stimulating Hormone Receptor (Active) Protein (AC1493) | 1 mg | inquiry |
| ACPP-1191 | Nogo Blocking Peptide (AC1191) | 250 µg | inquiry |
| ACPP-1715 | Mouse Acrp30 Protein, HEK (AC1715) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.